Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Tomentodiplacone B
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Silydianin
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Eryvarin M
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Rhamnetin
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Osajin
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Raddeanine
Potential treatment - theoretical effect Natural product Antiviral Oct/13/2020
Neochlorogenic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Forsythoside I
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Forsythiaside
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Rhein
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/10/2020
Lariciresinol
Potential treatment - theoretical effect Natural product Antiviral Oct/06/2020
Folic acid
Potential treatment - theoretical effect Natural product Antiviral Sep/24/2020
1-(3-Methoxy-4-hydroxyphenyl)-5-hydroxy-7-(3,4-dihydroxyphenyl)-3-heptanone
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Tricetin
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Aromadendrin
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Leucopelargonidin
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Arbutin
Potential treatment - theoretical effect Natural product Antiviral Sep/17/2020
Piperine
Potential treatment - theoretical effect Natural product Antiviral Sep/17/2020
Interferon lambda-1
Potential treatment - pre-clinical evidence Natural product Antiviral Sep/15/2020
Mahuang Liu Jun Tang
Potential treatment - clinical evidence Natural product Unknown Sep/14/2020